Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.\new Filed Acc 0001437749-16-031405

Options or other derivatives

  • Chief Financial Officer bought 58,260 shares at $1.25 ($72,825)

From the SEC's structured data for this filing

Trades in this filing

Arrow Alexander K. · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-04-15 Purchase : show line 1 in the form Series B Preferred Stock +40,000 $1.25 $50,000 100,000 D
2016-04-15 Purchase : show line 2 in the form Series B Preferred Stock +18,260 $1.25 $22,825 118,260 I
Loading xslF345X03/rdgdoc.xml…